It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The long isoform of Fas apoptosis inhibitory molecule (FAIM-L) is a neuron-specific death receptor antagonist that modulates apoptotic cell death and mechanisms of neuronal plasticity. FAIM-L exerts its antiapoptotic action by binding to X-linked inhibitor of apoptosis protein (XIAP), an inhibitor of caspases, which are the main effectors of apoptosis. XIAP levels are regulated by the ubiquitin-proteasome pathway. FAIM-L interaction with XIAP prevents the ubiquitination and degradation of the latter, thereby allowing it to inhibit caspase activation. This interaction also modulates non-apoptotic functions of caspases, such as the endocytosis of AMPA receptor (AMPAR) in hippocampal long-term depression (LTD). The molecular mechanism of action exerted by FAIM-L is unclear since the consensus binding motifs are still unknown. Here, we performed a two-hybrid screening to discover novel FAIM-L-interacting proteins. We found a functional interaction of SIVA-1 with FAIM-L. SIVA-1 is a proapoptotic protein that has the capacity to interact with XIAP. We describe how SIVA-1 regulates FAIM-L function by disrupting the interaction of FAIM-L with XIAP, thereby promoting XIAP ubiquitination, caspase-3 activation and neuronal death. Furthermore, we report that SIVA-1 plays a role in receptor internalization in synapses. SIVA-1 is upregulated upon chemical LTD induction, and it modulates AMPAR internalization via non-apoptotic activation of caspases. In summary, our findings uncover SIVA-1 as new functional partner of FAIM-L and demonstrate its role as a regulator of caspase activity in synaptic function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Cell Signaling and Apoptosis Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (GRID:grid.430994.3) (ISNI:0000 0004 1763 0287); Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Bellaterra, Spain (GRID:grid.7080.f)
2 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Institut de Neurociències, Universitat de Barcelona, Bellaterra, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); Institut de Neurociències, Universitat de Barcelona, Department of Cell Biology, Physiology and Immunology, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
3 Group of Translational Research in Child and Adolescent Cancer, Vall d’Hebron Research Institute (VHIR)-UAB, Barcelona, Spain (GRID:grid.430994.3) (ISNI:0000 0004 1763 0287)
4 Universitat de Lleida, Cell Cycle Laboratory, Institut de Recerca Biomèdica de Lleida (IRBLleida), and Departament de Ciències Mèdiques Bàsiques; Facultat de Medicina, Lleida, Spain (GRID:grid.15043.33) (ISNI:0000 0001 2163 1432)
5 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Institut de Neurociències, Universitat de Barcelona, Bellaterra, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); Institut de Neurociències, Universitat de Barcelona, Department of Cell Biology, Physiology and Immunology, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); ICREA Academia, Barcelona, Spain (GRID:grid.425902.8) (ISNI:0000 0000 9601 989X)
6 Cell Signaling and Apoptosis Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (GRID:grid.430994.3) (ISNI:0000 0004 1763 0287); Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Bellaterra, Spain (GRID:grid.7080.f); NYU Langone Health, Department of Pathology, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)